# Autopilot Checkpoint Log

Decisions logged here required human judgment but were resolved autonomously.
Review these after autopilot completes.

---

## Run: 2026-03-05T12:00:00Z
Tickets queued: input_hint_polish_core_mechanics.md

---

### [infection_interaction] Planner — Weakened state definition

**Would have asked:** Is the "weakened" enemy state already defined and implemented elsewhere?

**Assumption made:** Yes. EnemyStateMachine in the codebase already defines `STATE_WEAKENED` and transitions idle/active → weakened (weaken event), weakened → infected (infection event). Execution plan assumes dependency on enemy state machine / weakened-state behavior being in place; no separate task to define weakened.

**Confidence:** High

---

### [infection_interaction] Planner — Chunk contact vs key press

**Would have asked:** Should both chunk contact and key press trigger infection, or should the spec choose one?

**Assumption made:** Both are in scope per AC ("e.g. chunk contact, key press"). Spec Agent will define the exact interaction(s); implementation tasks include key/infect action (already present in InfectionInteractionHandler) and chunk-contact trigger (e.g. chunk body entering area of weakened enemy). If spec narrows to one trigger, implementation follows spec.

**Confidence:** Medium

---

### [infection_interaction] Planner — Existing infection code

**Would have asked:** The repo already has InfectionInteractionHandler, InfectionAbsorbResolver, MutationInventory, infection tests. Should the plan assume greenfield or align with existing code?

**Assumption made:** Plan drives spec-first. Spec is the authority; Test Design and Implementation tasks align or fill gaps. Existing code is reconciled with the spec (e.g. chunk-contact wiring may be missing; one mutation "usable" may need UI or gameplay hook). No task assumes delete-and-rewrite; implementation tasks may be "wire chunk contact," "ensure one mutation granted and visible/usable," "add/align visual feedback."

**Confidence:** High

---

### [infection_interaction] Planner — One mutation "usable"

**Would have asked:** What does "at least one mutation is granted and usable after absorb" mean — UI visibility only, or an actual gameplay effect?

**Assumption made:** Minimum: one mutation ID is granted to the player (MutationInventory.grant) and is visible or confirmable (e.g. in UI or inventory). "Usable" for this milestone means the player can observe that the mutation was gained; a concrete gameplay effect (e.g. stat buff, ability) may be placeholder or minimal. Spec Agent will clarify; implementation may deliver UI/inventory display plus a minimal placeholder effect if needed to satisfy AC.

**Confidence:** Medium

---

### [infection_interaction] Planner — Visual feedback scope

**Would have asked:** What level of visual/audio feedback is required for weakened, infected, and absorb states to count as "visually clear and discoverable without debug overlays"?

**Assumption made:** Minimum feedback includes distinct coloration or sprite change for weakened vs infected enemies, a short infection FX (e.g. pulse, particles) when infection occurs, and a clear on-screen cue when a mutation is gained (e.g. HUD toast or inventory highlight). No complex animation set is required for this milestone; Presentation and Spec Agents will choose the simplest assets/effects that satisfy clarity.

**Confidence:** Medium

---

### [infection_interaction] Planner — Softlock definition

**Would have asked:** For this feature, what scenarios count as a "softlock or undefined state" that must be prevented?

**Assumption made:** A softlock is any infection/absorb sequence that leaves the game running but the player unable to continue normal play without manually resetting the scene (e.g. enemy stuck in an intermediate state, infection cannot be cleared, absorb never completes, or mutation inventory enters an invalid state). Tests and implementation must ensure all transitions (normal, repeated, cancelled, or interrupted) converge to a valid, recoverable state: enemy dead or reset, infection cleared or resolved, and player input restored.

**Confidence:** Medium

---

### [infection_interaction] Test Designer — Infect input action coverage

**Would have asked:** Should primary tests assert that the `infect` input action (via `Input.is_action_just_pressed("infect")` in `InfectionInteractionHandler`) correctly routes to `EnemyStateMachine.apply_infection_event()` from weakened state, or is that mapping treated as higher-level engine integration?

**Assumption made:** For this ticket, primary Test Designer coverage focuses on pure logic and deterministic wiring that is testable without simulating real-time input. Infection triggers are verified at the state machine level and via chunk-contact engine wiring (`EnemyInfection._on_body_entered`), while the exact Godot input mapping for `infect` is treated as engine-integration / manual QA responsibility. No tests attempt to fake `Input` state.

**Confidence:** Medium

---

### [infection_interaction] Test Designer — Mutation "usable" via InfectionUI

**Would have asked:** Does "at least one mutation is granted and usable after absorb" require a concrete gameplay effect, or is a visible mutation indicator in the infection-loop HUD sufficient for this milestone?

**Assumption made:** For this milestone, a mutation is considered "usable" if it is (a) granted into `MutationInventory` and (b) made clearly visible to the player via InfectionUI (e.g. `MutationLabel`/`MutationIcon` driven from `get_mutation_inventory()` and `get_granted_count()`). Tests enforce that a non-zero mutation count makes the mutation label visible; any deeper gameplay effect is left to future tickets.

**Confidence:** Medium

---

### [infection_interaction] Test Designer — Infection FX text and tint mapping

**Would have asked:** Should the infection state FX contract specify exact label text and color tints for weakened/infected/dead, or only require that each state is visually distinct?

**Assumption made:** The strictest defensible contract for this ticket is that `infection_state_fx.gd` produces distinct visuals and explicit state labels: "Weakened", "Infected", and "Dead", with weakened/infected tinted away from the idle/default color and dead rendered dimmer (alpha < 1). Tests assert these concrete label strings and basic tint/dim relationships rather than exact RGB values, so future visual tweaks remain possible while keeping states clearly distinguishable.

**Confidence:** Medium

---

### [infection_interaction] Test Breaker — resolve_absorb null inventory semantics

**Would have asked:** When `InfectionAbsorbResolver.resolve_absorb` is invoked with a non-null, infected `EnemyStateMachine` but a null mutation inventory, should the resolver still kill the enemy or treat the call as a strict no-op?

**Assumption made:** For this ticket, calling `resolve_absorb` with a null inventory is treated as a strict no-op: the enemy state and mutation inventory must remain unchanged, and the call must never crash. Tests mark this as a CHECKPOINT and assert no state change when `inv == null`.

**Confidence:** Medium
---

### [input_hint_polish_core_mechanics] Planner — Duplicate ticket blocks

**Would have asked:** The ticket file for `input_hint_polish_core_mechanics` currently contains two full ticket blocks with different Revisions (2 and 1); should the lower block be treated as historical context and left untouched, or should the file be normalized to a single ticket definition?

**Assumption made:** The first ticket block (Revision 2) is the authoritative current state and the second block (Revision 1) is retained as historical context. For this run, only the first block's WORKFLOW STATE and NEXT ACTION fields will be updated (to Stage SPECIFICATION, Revision incremented, and handoff information adjusted), and the lower block will be left unchanged.

**Confidence:** Medium

---

### [infection_interaction] Test Breaker — workflow Stage enum vs IMPLEMENTATION_* domains

**Would have asked:** The workflow_enforcement_v1 Stage enum lists `IMPLEMENTATION_BACKEND/FRONTEND/GENERALIST`, while the infection_interaction execution plan and Test Breaker brief use implementation domains `Core Simulation`, `Gameplay Systems`, `Presentation`, and `Engine Integration`. Which specific IMPLEMENTATION_* Stage value should be used when handing off from Test Breaker to implementation for this ticket?

**Assumption made:** For this ticket, the authoritative domains are the ones used in the infection_interaction execution plan. Handoff from Test Breaker goes to `IMPLEMENTATION_CORE_SIMULATION` with `Next Responsible Agent` set to Core Simulation Agent, treating this as the correct IMPLEMENTATION_* Stage despite the older enum in workflow_enforcement_v1.

**Confidence:** Medium

---

### [infection_interaction] Core Simulation Agent — Preserve existing pure-logic implementations

**Would have asked:** Given that `EnemyStateMachine`, `InfectionAbsorbResolver`, and `MutationInventory` already exist and all primary + adversarial infection tests pass, should we refactor or tighten these modules further for this ticket, or treat the current implementations as authoritative if they satisfy R1–R4 and all CHECKPOINT assumptions?

**Assumption made:** For this ticket, the infection loop contract is defined by the existing tests and checkpoints. Since the current pure-logic implementations:
- use only the allowed state labels `{idle, active, weakened, infected, dead}`,
- enforce the specified transitions and no-op combinations,
- ensure `can_absorb`/`resolve_absorb` semantics (infected → dead + one mutation; no-op for invalid states or null args),
- and maintain MutationInventory invariants under all adversarial suites,
no additional refactoring is performed. The existing modules are treated as the canonical implementations for R1–R4 as long as the full infection test suite remains green.

**Confidence:** High

---

## Run: 2026-03-05T13:00:00Z
Tickets queued: infection_interaction.md

---

### [infection_interaction] Planner — Project name field

**Would have asked:** What value should the `Project` field use for the `infection_interaction` ticket (e.g. `blobert` vs `Milestone 2 – Infection Loop`)?

**Assumption made:** Use `blobert` as the canonical project name, with milestone and epic context captured in the ticket body and folder structure rather than the `Project` field itself.

**Confidence:** High

---

### [infection_interaction] Planner — Implementation stage vs domain agents

**Would have asked:** Given the Stage enum in `workflow_enforcement_v1` only includes `IMPLEMENTATION_BACKEND | IMPLEMENTATION_FRONTEND | IMPLEMENTATION_GENERALIST`, but the infection loop uses domain-specific agents (Core Simulation, Gameplay Systems, Engine Integration, Presentation), which Stage value should be used when handing off to implementation?

**Assumption made:** Continue to use the documented enum and set Stage to `IMPLEMENTATION_GENERALIST` for all implementation-domain handoffs, while using `Next Responsible Agent` to name the specific domain agent (e.g. `Core Simulation Agent`, `Gameplay Systems Agent`). No new Stage values are introduced.

**Confidence:** Medium

---

### [infection_interaction] Spec — Canonical infection trigger

**Would have asked:** For this milestone, should the spec treat chunk contact, an explicit `infect` input action, or both as the required way to infect a weakened enemy?

**Assumption made:** The canonical, testable contract for this ticket is chunk-based contact: when an infecting slime chunk body enters a weakened enemy's infection area, infection is triggered if the enemy is eligible. Any `infect` input action wiring is treated as higher-level engine integration and is not required for this spec to be satisfied.

**Confidence:** Medium

---

### [infection_interaction] Spec — Infection eligibility scope

**Would have asked:** Do all enemies support being weakened and infected, or only a subset tagged/configured for infection in this milestone?

**Assumption made:** Only enemies whose state is driven by `EnemyStateMachine` and are explicitly configured/marked as infection-eligible in the scene or data are in scope. Other enemies remain non-infectable for this milestone and are allowed to ignore chunk contact entirely.

**Confidence:** Medium

---

### [infection_interaction] Spec — Mutation selection rule

**Would have asked:** When absorbing an infected enemy, if multiple mutation types exist, should the granted mutation be random, cyclic, or fixed?

**Assumption made:** For this milestone, mutation granting is deterministic and fixed: absorbing an infected enemy always grants a single, configured mutation ID (e.g. the first entry in a small infection-mutation config), with no randomness. This keeps tests and player expectations stable while still delivering "at least one mutation."

**Confidence:** Medium

---

### [infection_interaction] Spec — Repeated infection attempts

**Would have asked:** What should happen if infection is triggered against an enemy that is already infected or dead?

**Assumption made:** Infection is strictly one-way and idempotent: chunk contact that does not find the enemy in the weakened state (e.g. idle, active, infected, dead) has no effect and must not change enemy or player state. Only weakened → infected is allowed for this ticket.

**Confidence:** High

---

### [infection_interaction] Spec — Multiple absorbs and mutation stacking

**Would have asked:** If the player infects and absorbs multiple enemies in sequence, should mutations stack, replace the previous one, or be capped for this milestone?

**Assumption made:** Each successful absorb from an infected enemy increments the stored mutation count by 1 (via `MutationInventory`) with no explicit upper cap for this ticket. The acceptance criteria only require that at least one mutation is granted and visible/usable; additional absorbs are allowed but not strictly required to be showcased in UX beyond a monotonically increasing count.

**Confidence:** Medium

---

### [infection_interaction] Spec — Out-of-scope systems

**Would have asked:** Should infection state and mutations be persisted across scene reloads/checkpoints or integrated with broader progression, or is this milestone limited to single-session, in-level behavior?

**Assumption made:** For this ticket, infection and mutation effects are scoped to the current play session/scene. Save/load, cross-level persistence, and meta-progression are explicitly out of scope and may be handled by future tickets.

**Confidence:** High

---

### [infection_interaction] Test Breaker — EnemyInfection player targeting wiring

**Would have asked:** Should `EnemyInfection` be required to always set and clear the current absorb target via `InfectionInteractionHandler.set_target_esm` and `clear_target` exactly once per player enter/exit, and never in response to chunk contact?

**Assumption made:** For this ticket, the conservative contract is that entering an enemy's infection area with a body in the `player` group calls `InfectionInteractionHandler.set_target_esm` once with that enemy's `EnemyStateMachine`, exiting calls `clear_target` once, and chunk-contact infection (`body in group "chunk"`) must not change the handler's target at all. Tests treat any deviation (missing set/clear or handler calls from chunk-only contact) as a failure.

**Confidence:** Medium

---

### [infection_interaction] — OUTCOME: COMPLETE
All automated infection interaction suites (primary + adversarial) are passing and a human has verified in-editor that infection/absorb visuals and UX satisfy the final acceptance criterion; ticket is marked COMPLETE and moved to the milestone's done column.

## Run: 2026-03-05T14:00:00Z
Tickets queued: mutation_slot_system_single.md

---

### [mutation_slot_system_single] Orchestrator — Missing workflow state blocks

**Would have asked:** The ticket `mutation_slot_system_single` currently lacks WORKFLOW STATE and NEXT ACTION sections; should the orchestrator normalize the ticket structure before handing off to Planner, or allow Planner to create the initial workflow blocks?

**Assumption made:** Treat the ticket as newly activated. Move it from the milestone backlog into `01_active/` without modifying its content, rely on the folder rule (`01_active/` → active, non-COMPLETE Stage) and delegate normalization of WORKFLOW STATE and NEXT ACTION to the Planner agent as part of Stage PLANNING.

**Confidence:** Medium

---

### [mutation_slot_system_single] — OUTCOME: INTEGRATION (Human verification required)
Automated tests, core simulation, gameplay wiring, engine integration, and HUD presentation for the single mutation slot are all implemented and passing; ticket is parked in Stage INTEGRATION with explicit Blocking Issues for a human to verify in-editor that the slot UX is human-playable, clearly indicates filled/empty state and active mutation, and that no duplicate or lost mutations occur in realistic play.

### [mutation_slot_system_single] Planner — Relationship to MutationInventory

**Would have asked:** Should the single mutation slot be modeled as a separate system from `MutationInventory`, or is the slot effectively "the currently equipped mutation" backed by `MutationInventory` as the source of granted mutations?

**Assumption made:** The mutation slot system is a thin layer over the existing `MutationInventory`: absorbs continue to grant mutations into the inventory, and the slot tracks which single mutation (by ID) is currently active/equipped. The slot never owns data independently of the inventory; it only references or selects from it, and implementation tasks will keep inventory and slot state consistent.

**Confidence:** Medium

---

### [mutation_slot_system_single] Planner — Slot consumption vs persistence

**Would have asked:** When the player "uses" the mutation in the slot, should that usage consume and clear the slot, or does the slot remain filled with a passive or repeatable effect until explicitly replaced?

**Assumption made:** For this milestone, the conservative contract is that the slot represents a persistent, always-on mutation once filled. Using the mutation expresses its effect (e.g. passive stat change or repeatable ability) but does not automatically clear the slot; the slot is only changed when a new mutation is equipped or explicitly replaced by design. Spec and tests will treat one filled slot with persistent effect as the minimum required behavior.

**Confidence:** Medium

---

### [mutation_slot_system_single] Planner — Multiple granted mutations

**Would have asked:** If the player absorbs multiple enemies and gains multiple mutations, how should the single slot choose which mutation is active (first granted, last granted, configurable selection, or other rule)?

**Assumption made:** For this ticket, the selection rule is deterministic and simple: the active slot always tracks the most recently granted compatible mutation (last-wins). Additional inventory capacity or multi-mutation management is out of scope; tests and spec will only require that the latest valid mutation from an absorb becomes the active slot content, with previous slot contents replaced but inventory history remaining consistent.

**Confidence:** Medium

---

### [mutation_slot_system_single] Planner — Scope of persistence and save/load

**Would have asked:** Should the mutation slot contents and its active effect persist across scene reloads/checkpoints or be scoped only to the current play session/scene?

**Assumption made:** In line with other Milestone 2 infection-loop tickets, the mutation slot is scoped to the current play session/scene. Persistence across saves, level transitions, or meta-progression is explicitly out of scope for this ticket and can be handled by future progression/persistence features.

**Confidence:** High

---

### [mutation_slot_system_single] Spec — Slot vs effect gating

**Would have asked:** For this milestone, should the active mutation slot state be the *only* authority for enabling/disabling the mutation's gameplay effect, or can the existing implementation that ties the effect directly to `MutationInventory` remain unchanged as long as slot state accurately mirrors inventory?

**Assumption made:** To keep scope minimal and avoid destabilizing the existing infection loop, the mutation effect remains bound to the presence of at least one granted mutation in `MutationInventory` as implemented for `infection_interaction`. The new single-slot layer must accurately reflect that state (empty before any grants, filled after the first successful absorb, last-wins on later grants) but is not required to introduce an additional layer of effect gating beyond inventory for this milestone.

**Confidence:** Medium

---

### [mutation_slot_system_single] Test Designer — MutationSlot empty sentinel and API surface

**Would have asked:** When the slot is empty, should `MutationSlot.get_active_mutation_id()` return an empty string, `null`, or a dedicated sentinel constant, and what minimum write API should the slot expose for tests to drive SLOT-1/SLOT-2 behavior?

**Assumption made:** The strictest defensible contract is that `get_active_mutation_id()` returns the empty string `""` whenever the slot is empty, and that the slot exposes a minimal, explicit write API `set_active_mutation_id(id: String)` plus `clear()`. Tests assert the empty-string sentinel and drive all state changes through `set_active_mutation_id` and `clear` rather than relying on implicit side effects so that any future change to the sentinel or write semantics is intentional and requires coordinated spec/test updates.

**Confidence:** Medium

---

### [mutation_slot_system_single] Test Breaker — Empty slot ID write semantics

**Would have asked:** When `MutationSlot.set_active_mutation_id("")` is called, should the slot treat the empty string as a real mutation ID (leaving the slot filled) or interpret it as "clear the slot" to keep the empty-string sentinel semantics consistent?

**Assumption made:** For this ticket, the conservative contract is that `set_active_mutation_id("")` is equivalent to `clear()`: after the call, `is_filled()` must be `false` and `get_active_mutation_id()` must return the empty string sentinel `""`, ensuring the slot never reports itself as filled with an empty ID.

**Confidence:** Medium

---

### [mutation_slot_system_single] Core Simulation Agent — InfectionAbsorbResolver slot parameter

**Would have asked:** Should `InfectionAbsorbResolver.resolve_absorb` be extended to take a `MutationSlot` parameter directly, or should slot updates be handled entirely by higher-level coordination code outside the resolver?

**Assumption made:** To keep integration minimal and deterministic while honoring the SLOT-2 spec, `resolve_absorb` is extended with an optional third `slot: Object = null` parameter. Existing call sites that pass only `(esm, inv)` continue to behave identically, and when a non-null slot implementing `set_active_mutation_id(id: String)` is provided and absorb succeeds, the resolver calls `slot.set_active_mutation_id(DEFAULT_MUTATION_ID)` immediately after `inv.grant(DEFAULT_MUTATION_ID)`. If `slot` is null or lacks the method, it is ignored.

**Confidence:** Medium

---

### [mutation_slot_system_single] Gameplay Systems Agent — Slot owner and gameplay access

**Would have asked:** In the infection-loop scene, which runtime object should own the authoritative `MutationSlot` instance for the player (e.g. `PlayerController`, `InfectionInteractionHandler`, a dedicated mutation controller node, or a global singleton)?

**Assumption made:** `InfectionInteractionHandler` owns the canonical `MutationSlot` instance for the player: it instantiates `MutationSlot` once in `_ready()`, passes it into `InfectionAbsorbResolver.resolve_absorb(esm, inv, slot)` whenever an absorb succeeds, and exposes it via `get_mutation_slot()` so gameplay systems like `PlayerController` and `InfectionUI` can read slot state without introducing new autoloads or duplicating slot instances.

**Confidence:** Medium

---

## Run: 2026-03-12T00:00:00Z
Tickets queued: fusion_opportunity_room.md

---

### [fusion_opportunity_room] Planner — Dependency on fusion_rules_and_hybrid.md and visual_clarity_hybrid_state.md

**Would have asked:** The fusion mechanic (fusion_rules_and_hybrid.md) and hybrid visual feedback (visual_clarity_hybrid_state.md) are both listed as Backlog and not yet implemented. Can the fusion opportunity room be specced and laid out before those tickets are completed, or must they ship first?

**Assumption made:** The room layout, enemy placement, and infection loop for two enemies are fully specifiable and buildable without a working fusion implementation. The fusion trigger and hybrid feedback are treated as a hard dependency only for the final AC ("at least one fusion can be performed in-level with clear feedback"). Tasks in this plan are ordered so the room structure is built first, and the fusion-trigger wiring task explicitly depends on fusion_rules_and_hybrid.md being implemented. The spec will document the fusion trigger as a TBD placeholder resolved by that downstream ticket.

**Confidence:** High

---

### [fusion_opportunity_room] Planner — Containment Hall 01 scene existence

**Would have asked:** Does `containment_hall_01.tscn` already exist as a buildable scene, or does it need to be created as part of this ticket?

**Assumption made:** `containment_hall_01.tscn` does not yet exist in the repository (not found in `/Users/jacobbrandt/workspace/blobert/scenes/`). This ticket must create it. The scene will be built as a new 3D scene using CharacterBody3D, StaticBody3D (floors/walls), and Area3D nodes consistent with the project's 3D conventions. The containment_hall_01_layout.md ticket (also in_progress) covers the full level; this ticket scopes only the fusion room sub-area within that level.

**Confidence:** Medium

---

### [fusion_opportunity_room] Planner — Fusion room scope within containment_hall_01

**Would have asked:** Should the fusion opportunity room be a fully self-contained scene (its own .tscn), a sub-scene instanced into containment_hall_01.tscn, or a region within a monolithic containment_hall_01.tscn?

**Assumption made:** The fusion room is a spatially distinct chamber within a single `containment_hall_01.tscn` (not a separate scene file). It is laid out as a named sub-region (e.g. a Node3D group named "FusionRoom") inside the hall. This keeps scene management consistent with existing project conventions (one scene per level area) and makes it easy to test in isolation by temporarily setting it as the run/main_scene.

**Confidence:** Medium

---

### [fusion_opportunity_room] Planner — Enemy type and mutation IDs for the two room enemies

**Would have asked:** What specific mutation IDs should each enemy in the fusion room grant? Should each grant a different mutation ID so the two slots receive distinct mutations?

**Assumption made:** Two enemies are placed in the fusion room. Enemy A (on Platform A) grants mutation ID `"mutation_a"` and Enemy B (on Platform B) grants `"mutation_b"`. These are placeholder IDs consistent with the deterministic-mutation-ID assumption from prior checkpoints. The Spec Agent will finalize the exact IDs; implementation uses these as named constants so a single-line change updates both. Each enemy must grant a different ID so both slots fill with distinct values, enabling a deterministic fusion outcome.

**Confidence:** Medium

---

### [fusion_opportunity_room] Planner — Fusion trigger mechanic

**Would have asked:** How is fusion triggered in the room — is it an input action the player presses when both slots are full, an automatic trigger on entering a specific zone, or something else?

**Assumption made:** Fusion is triggered by an explicit player input action (`"fuse"`) when both mutation slots are filled, consistent with the fusion_rules_and_hybrid.md AC ("Fusion is triggered by defined input/condition when two slots are filled"). No automatic zone trigger is added; a UI prompt or on-screen hint will appear when both slots are filled. The Spec Agent will confirm the exact action name; if fusion_rules_and_hybrid.md defines a different trigger, that definition is authoritative.

**Confidence:** Medium

---

### [fusion_opportunity_room] Planner — What "platform" means in 2.5D context

**Would have asked:** For the 2.5D side-scrolling game, do "platforms" mean elevated StaticBody3D floors the player can jump onto, or some other structure?

**Assumption made:** Platforms are StaticBody3D + CollisionShape3D + MeshInstance3D nodes elevated above the room floor, reachable by the player via jumping with existing movement physics. Each enemy stands on one platform. Platform heights are set so the player can reach them with the default CharacterBody3D jump implemented in player_controller_3d.gd. No additional movement mechanics are required.

**Confidence:** High

---

### [fusion_opportunity_room] Planner — In-editor playability requirement

**Would have asked:** The AC requires the room be "human-playable in-editor." Does this require running from containment_hall_01.tscn directly, or is running from test_movement_3d.tscn acceptable if the room is reachable?

**Assumption made:** "Human-playable in-editor" means the Godot editor can run the scene and a human can navigate through the fusion room, absorb both enemies, and observe the fusion trigger/outcome without debug overlays. For this ticket, the room must be runnable either as a standalone scene or reachable from a valid main scene. The implementation task will ensure the room is loadable by setting it as the main scene temporarily or making it reachable from test_movement_3d.tscn.

**Confidence:** Medium

---

### [autopilot] Orchestrator — API rate limit hit mid-run
**Would have asked:** Multiple background agents hit "You've hit your limit · resets 10pm (America/New_York)" simultaneously. The test breaker for second_chunk_logic and planners for fusion_rules_and_hybrid, visual_clarity_hybrid_state, containment_hall_01_layout, mutation_tease_room, fusion_opportunity_room, light_skill_check, mini_boss_encounter, start_finish_flow were all blocked. Should these tickets be marked BLOCKED or left in their current stage pending retry?
**Assumption made:** These tickets are left at their current stage (PLANNING for most, TEST_BREAK for second_chunk_logic). The rate limit is temporary and resets at 10pm ET. The next autopilot run should resume from each ticket's current stage. No ticket content is corrupted — agents that failed produced no changes.
**Confidence:** High

### [slot_consumption_rules] — OUTCOME: PLANNING COMPLETE
Planner Agent completed full execution plan before rate limit. Ticket at SPECIFICATION, Spec Agent is next. Key decision: consume_fusion_slots() method on MutationSlotManager; all-or-nothing slot clear after fusion.

